An article recently published in PLOS One by Prof. Gayatri Saberwal and team regarding the status of clinical trials in India has received extensive media coverage:”Mendiratta J, Vaswani R N, Saberwal G. Representation from India in multinational, interventional, Phase 2 or 3 trials registered in Clinical Trials Registry-India: A cross-sectional study. PLOS ONE, 18(9): e0284434.”https://doi.org/10.1371/journal.pone.0284434 (2023)
- Guinea pigs: Editorial on the excessive use of Indians in global clinical trials
Editorial, 2 October 2023
www.telegraphindia.com/opinion/guinea-pigs-editorial-on-the-excessive-use-of-indians-in-global-clinical-trials/cid/1970402 - Study throws light on excessive use of Indians in global clinical trials
by G.S. Mudur, 25 Sept 2023
https://www.telegraphindia.com/india/study-throws-light-on-excessive-use-of-indians-in-global-clinical-trials/cid/1968685] - Research finds over-recruitment of Indian participants in global clinical trials
by Abhishek Awasthi, 25 Sept 2023
ct.moreover.com/?a=51892518663&p=1pl&v=1&x=1-aLtb-NHVq9nKqQcb1Q1Q - Clinical trials of new drugs over-recruiting Indians: Study
by Teena Thacker, 27 Sept 2023
https://health.economictimes.indiatimes.com/news/industry/clinical-trials-of-new-drugs-over-recruiting-indians-study/103970407